Classical Swine Fever (CSV) has for the most part been eradicated in Canada, the US, Mexico and western Europe. Although the disease is still present in parts of Asia and the Caribbean. The disease has potential to cause massive economic losses if it is able to infect a herd. If a case is detected it must be reported to the World Organization for Animal Health. The objective of this study was to develop and validate enzyme-linked immunosorbent assay ELISA capable of detecting anti-bodies to as many CFVS strains as possible. The objectives of this study have yet to be completed including the development of a rapid test for detecting classical swine fever virus although work is still being done to achieve the end goal. In the coming months there are plans to continue to optimizing the competitive ELISA format using the new lot of recombinant Paderborn E2 antigen. Once all conditions for the cELISA have been optimized, analytic sensitivity and specificity along with limited diagnostic sensitivity and specificity will be evaluated using a bank of highly characterized CSFV antisera. The development of this test system will help pork producers easily test for CSFV and be able to respond faster to an outbreak keeping Canadian pork available for trade.